Lymphocyte-Activation Gene 3 (LAG3) (C-Term) Peptide
LAG3
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN979169
Quick Overview for Lymphocyte-Activation Gene 3 (LAG3) (C-Term) Peptide (ABIN979169)
Target
LAG3
(Lymphocyte-Activation Gene 3 (LAG3))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- C-Term
-
Sequence
- GFHLWRRQWR PRRFSALEQG IHPPQAQSKI EELEQEPEPE PEPEPEPEPE
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-LAG3 Antibody(ARP59142_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
-
Background
-
Lymphocyte-activation protein 3 belongs to Ig superfamily and contains 4 extracellular Ig-like domains. The LAG3 gene contains 8 exons. The sequence data, exon/intron organization, and chromosomal localization all indicate a close relationship of LAG3 to CD4.
Alias Symbols: CD223
Protein Interaction Partner: CEBPZ,CENPJ
Protein Size: 525 -
Molecular Weight
- 55 kDa
-
Gene ID
- 3902
-
NCBI Accession
- NM_002286, NP_002277
-
UniProt
- P18627
Target
-
You are here:
